3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
42
Colonic Neoplasms
14
Rectal Neoplasms
13
Neoplasms
12
Neoplasm Metastasis
12
Head and Neck Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Squamous Cell
4
Breast Neoplasms
4
Recurrence
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Gastrointestinal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Tumors
1
Ovarian Neoplasms
1
Inflammatory Breast Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Exanthema
1
Interventions
tislelizumab
4
talazoparib
4
pembrolizumab
4
Docetaxel
4
Nivolumab
3
PM 01183
2
MLN 8237
2
Itraconazole
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
zimberelimab
1
utomilumab
1
urelumab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sitravatinib
1
sapanisertib
1
pexidartinib
1
pevonedistat
1
peposertib
1
niraparib
1
mogamulizumab
1
lenvatinib
1
ixabepilone
1
eribulin
1
durvalumab
1
dalotuzumab
1
avelumab
1
ascrinvacumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
Panitumumab
×
Clear all
No trials found.